Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-10-011569
Filing Date
2010-02-23
Accepted
2010-02-23 19:41:24
Documents
2
Period of Report
2010-02-23

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION c96687_3x1.html 3  
1 MAIN DOCUMENT DESCRIPTION c96687_3x1.xml 3 6056
2 POWER OF ATTORNEY c96687_24.htm EX-24 5838
  Complete submission text file 0001209191-10-011569.txt   13716
Mailing Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545
Business Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545 (510) 856-5600
Anthera Pharmaceuticals Inc (Issuer) CIK: 0001316175 (see all company filings)

EIN.: 201852016 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ANTHERA PHARMACEUTICALS, INC. 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545
Business Address
Trias Joaquim (Reporting) CIK: 0001483998 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-34637 | Film No.: 10627964